Using theonellasterol as a novel FXR antagonist hit, we prepared a series of semi-synthetic derivatives in order to gain insight into the structural requirements for exhibiting antagonistic activity. These derivatives are characterized by modification at the exocyclic carbon-carbon double bond at C-4 and at the hydroxyl group at C-3 and were prepared from theonellasterol using simple reactions. Pharmacological investigation showed that the introduction of a hydroxyl group at C-4 as well as the oxidation at C-3 with or without concomitant modification at the exomethylene functionality preserve the ability of theonellasterol to inhibit FXR transactivation caused by CDCA. Docking analysis showed that the placement of these molecules in the FXR-LBD is well stabilized when on ring A functional groups, able to form hydrogen bonds and π interactions, are present.
References
[1]
Kho, E.; Imagawa, D.K.; Rohmer, M.; Kashman, Y.; Djerassi, C. Sterols in marine invertebrates. 22. Isolation and structure elucidation of conicasterol and theonellasterol, two new 4-methylene sterols from the Red Sea sponges Theonella conica and Theonella swinhoei. J. Org. Chem. 1981, 46, 1836–1839.
[2]
Festa, C.; De Marino, S.; Sepe, V.; Monti, M.C.; Luciano, P.; D’Auria, M.V.; Debitus, C.; Bucci, M.; Vellecco, V.; Zampella, A. Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei. Tetrahedron 2009, 65, 10424–10429.
[3]
Margarucci, L.; Monti, M.C.; Mencarelli, A.; Fiorucci, S.; Riccio, R.; Zampella, A.; Casapullo, A. Heat shock proteins as key biological targets of the marine natural cyclopeptide perthamide C. Mol. BioSyst. 2012, 8, 1412–1417, doi:10.1039/c2mb05507d.
[4]
Sepe, V.; D’Auria, M.V.; Bifulco, G.; Ummarino, R.; Zampella, A. Concise synthesis of AHMHA unit in perthamide C. Structural and stereochemical revision of perthamide C. Tetrahedron 2010, 66, 7520–7526.
[5]
Festa, C.; De Marino, S.; Sepe, V.; D’Auria, M.V.; Bifulco, G.; Andres, R.; Terencio, M.C.; Paya, M.; Debitus, C.; Zampella, A. Perthamides C-F, potent human antipsoriatic cyclopeptides. Tetrahedron 2011, 67, 7780–7786, doi:10.1016/j.tet.2011.07.077.
[6]
Festa, C.; De Marino, S.; D’Auria, M.V.; Monti, M.C.; Bucci, M.; Vellecco, V.; Debitus, C.; Zampella, A. Anti-Inflammatory cyclopeptides from the marine sponge Theonella swinhoei. Tetrahedron 2012, 68, 2851–2857, doi:10.1016/j.tet.2012.01.097.
[7]
Festa, C.; De Marino, S.; Sepe, V.; D’Auria, M.V.; Bifulco, G.; Debitus, C.; Bucci, M.; Vellecco, V.; Zampella, A. Solomonamides A and B, new anti-inflammatory peptides from Theonella swinhoei. Org. Lett. 2011, 13, 1532–1535, doi:10.1021/ol200221n.
[8]
Festa, C.; De Marino, S.; D’Auria, M.V.; Bifulco, G.; Renga, B.; Fiorucci, S.; Petek, S.; Zampella, A. Solomonsterols A and B from Theonella swinhoei. The first example of C-24 and C-23 sulfated sterols from a marine source endowed with a PXR agonistic activity. J. Med. Chem. 2011, 54, 401–405.
[9]
Sepe, V.; Ummarino, R.; D’Auria, M.V.; Mencarelli, A.; D’Amore, C.; Renga, B.; Zampella, A.; Fiorucci, S. Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. J. Med. Chem. 2011, 54, 4590–4599, doi:10.1021/jm200241s.
[10]
Sepe, V.; Ummarino, R.; D’Auria, M.V.; Renga, B.; Fiorucci, S.; Zampella, A. The first total synthesis of solomonsterol B, a marine pregnane X receptor agonist. Eur. J. Org. Chem. 2012, 27, 5187–5194.
[11]
Sepe, V.; Ummarino, R.; D’Auria, M.V.; Lauro, G.; Bifulco, G.; D’Amore, C.; Renga, B.; Fiorucci, S.; Zampella, A. Modification in the side chain of solomonsterol A: Discovery of cholestan disulfate as a potent pregnane-X-receptor agonist. Org. Biomol. Chem. 2012, 10, 6350–6362, doi:10.1039/c2ob25800e.
[12]
De Marino, S.; Festa, C.; D’Auria, M.V.; Cresteil, T.; Debitus, C.; Zampella, A. Swinholide J, a potent cytotoxin from the marine sponge Theonella swinhoei. Mar. Drugs 2011, 9, 1133–1141, doi:10.3390/md9061133.
[13]
De Marino, S.; Ummarino, R.; D’Auria, M.V.; Chini, M.G.; Bifulco, G.; Renga, B.; D’Amore, C.; Fiorucci, S.; Debitus, C.; Zampella, A. Theonellasterols and conicasterols from Theonella swinhoei. Novel marine natural ligands for human nuclear receptors. J. Med. Chem. 2011, 54, 3065–3075, doi:10.1021/jm200169t.
[14]
De Marino, S.; Sepe, V.; D’Auria, M.V.; Bifulco, G.; Renga, B.; Petek, S.; Fiorucci, S.; Zampella, A. Towards new ligands of nuclear receptors. Discovery of malaitasterol A, an unique bis-secosterol from marine sponge Theonella swinhoei. Org. Biomol. Chem. 2011, 9, 4856–4862.
[15]
Sepe, V.; Ummarino, R.; D’Auria, M.V.; Chini, M.G.; Bifulco, G.; Renga, B.; D’Amore, C.; Debitus, C.; Fiorucci, S.; Zampella, A. Conicasterol E, a small heterodimer partner sparing farnesoid X receptor modulator endowed with a pregnane X receptor agonistic activity, from the marine sponge Theonella swinhoei. J. Med. Chem. 2012, 55, 84–93, doi:10.1021/jm201004p.
[16]
Chini, M.G.; Jones, C.R.; Zampella, A.; D’Auria, M.V.; Renga, B.; Fiorucci, S.; Butts, C.P.; Bifulco, G. Quantitative NMR-derived interproton distances combined with quantum mechanical calculations of 13C chemical shifts in the stereochemical determination of conicasterol F, a nuclear receptor ligand from Theonella swinhoei. J. Org. Chem. 2012, 77, 1489–1496, doi:10.1021/jo2023763.
[17]
De Marino, S.; Ummarino, R.; D’Auria, M.V.; Chini, M.G.; Bifulco, G.; D’Amore, C.; Renga, B.; Mencarelli, A.; Petek, S.; Fiorucci, S.; Zampella, A. 4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. Steroids 2012, 77, 484–495, doi:10.1016/j.steroids.2012.01.006.
Pellicciari, R.; Costantino, G.; Fiorucci, S. Farnesoid X receptor: From structure to potential clinical applications. J. Med. Chem. 2005, 48, 5383–5403, doi:10.1021/jm0582221.
[20]
Fiorucci, S.; Rizzo, G.; Donini, A.; Distrutti, E.; Santucci, L. Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol. Med. 2007, 13, 298–309, doi:10.1016/j.molmed.2007.06.001.
[21]
Sonoda, J.; Xie, W.; Rosenfeld, J.M.; Barwick, J.L.; Guzelian, P.S.; Evans, R.M. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc. Natl. Acad. Sci. USA 2002, 99, 13801–13806.
[22]
Guo, G.L.; Lambert, G.; Negishi, M.; Ward, J.M.; Brewer, H.B.J.; Kliewer, S.A.; Gonzalez, F.J.; Sinal, C.J. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity. J. Biol. Chem. 2003, 278, 45062–45071.
[23]
Fiorucci, S.; Cipriani, S.; Mencarelli, A.; Baldelli, F.; Bifulco, G.; Zampella, A. Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: Focus on 6-ethyl-CDCA. Mini Rev. Med. Chem. 2011, 11, 753–762, doi:10.2174/138955711796355258.
[24]
Kakizaki, S.; Takizawa, D.; Tojima, H.; Horiguchi, N.; Yamazaki, Y.; Mori, M. Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease. Front Biosci. 2011, 17, 2988–3005.
[25]
Fiorucci, S.; Zampella, A.; Distrutti, E. Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders. Curr. Top. Med. Chem. 2012, 6, 605–624.
[26]
Poupon, R.E.; Bonnand, A.M.; Chrétien, Y.; Poupon, R. Ten-Year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Hepatology 1999, 29, 1668–1671, doi:10.1002/hep.510290603.
[27]
Parés, A.; Caballería, L.; Rodés, J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006, 130, 715–720, doi:10.1053/j.gastro.2005.12.029.
[28]
Renga, B.; Mencarelli, A.; D’Amore, C.; Cipriani, S.; D’Auria, M.V.; Sepe, V.; Chini, M.G.; Monti, M.C.; Bifulco, G.; Zampella, A.; Fiorucci, S. Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. PLoS One 2012, 7, e30443.
[29]
Sepe, V.; Bifulco, G.; Renga, B.; D’Amore, C.; Fiorucci, S.; Zampella, A. Discovery of sulfated sterols from marine invertebrates as a new class of marine natural antagonists of farnesoid-X-receptor. J. Med. Chem. 2011, 54, 1314–1320, doi:10.1021/jm101336m.
[30]
D’Auria, M.V.; Sepe, V.; Zampella, A. Natural ligands for nuclear receptors: Biology and potential therapeutic applications. Curr. Top. Med. Chem. 2012, 12, 637–690, doi:10.2174/156802612799436650.
[31]
Pellicciari, R.; Gioiello, A.; Costantino, G.; Sadeghpour, B.M.; Rizzo, G.; Meyer, U.; Parks, D.J.; Entrena-Guadix, A.; Fiorucci, S. Back door modulation of the farnesoid X receptor: Design, synthesis, and biological evaluation of a series of side chain modified chenodeoxycholic acid derivatives. J. Med. Chem. 2006, 49, 4208–4215, doi:10.1021/jm060294k.
[32]
Mi, L.Z.; Devarakonda, S.; Harp, J.M.; Han, Q.; Pellicciari, R.; Willson, T.M.; Khorasanizadeh, S.; Rastinejad, F. Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol. Cell 2003, 11, 1093–1100, doi:10.1016/S1097-2765(03)00112-6.
[33]
Schmidt, A.W.; Doert, T.; Goutal, S.; Gruner, M.; Mende, F.; Kurzchalia, T.V.; Kn？lker, H.J. Regio- and stereospecific synthesis of cholesterol derivatives and their hormonal activity in Caenorhabditis elegans. Eur. J. Org. Chem. 2006, 16, 3687–3706.
[34]
Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785–2791, doi:10.1002/jcc.21256.
[35]
Sanner, M.F. A programming language for software integration and development. J. Mol. Graphics 1999, 17, 57–61.
